Helen Cox

Prof. Helen Cox

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in British Journal of Pharmacology
Verified
Journal Article
Open access
SASteve Alexander
Steve Alexander
ACArthur Christopoulos
Arthur Christopoulos
ADAnthony P. Davenport
Anthony P. Davenport
EKEamonn Kelly
Eamonn Kelly
AMAlistair A. Mathie
Alistair A. Mathie
RYRichard D. Ye
Richard D. Ye
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (https://www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.16177. G protein‐coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

1 December 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BHBirgitte Holst
Birgitte Holst
NHNicholas D. Holliday
Nicholas D. Holliday
ABAnders Bach
Anders Bach
CEChristian E. Elling
Christian E. Elling
HCHelen Cox
Helen Cox
TSThue W. Schwartz
Thue W. Schwartz
Three members of the ghrelin receptor family were characterized in parallel: the ghrelin receptor, the neurotensin receptor 2 and the orphan receptor GPR39. In transiently transfected COS-7 and human embryonic kidney 293 cells, all three receptors displayed a high degree of ligand-independent signaling activity. The structurally homologous motilin receptor served as a constitutively silent control; upon agonist stimulation, however, it signaled with a similar efficacy to the three related receptors. The constitutive activity of the ghrelin receptor and of neurotensin receptor 2 through the G(q), phospholipase C pathway was approximately 50% of their maximal capacity as determined through inositol phosphate accumulation. These two receptors also showed very high constitutive activity in activation of cAMP response element-driven transcription. GPR39 displayed a clear but lower degree of constitutive activity through the inositol phosphate and cAMP response element pathways. In contrast, GPR39 signaled with the highest constitutive activity in respect of activation of serum response element-dependent transcription, in part, possibly, through G(12/13) and Rho kinase. Antibody feeding experiments demonstrated that the epitope-tagged ghrelin receptor was constitutively internalized but could be trapped at the cell surface by an inverse agonist, whereas GPR39 remained at the cell surface. Mutational analysis showed that the constitutive activity of both the ghrelin receptor and GPR39 could systematically be tuned up and down depending on the size and hydrophobicity of the side chain in position VI:16 in the context of an aromatic residue at VII:09 and a large hydrophobic residue at VII:06. It is concluded that the three ghrelin-like receptors display an unusually high degree of constitutive activity, the structural basis for which is determined by an aromatic cluster on the inner face of the extracellular ends of TMs VI and VII.

18 June 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Amanda Sainsbury-SalisAmanda Sainsbury-Salis
Amanda Sainsbury-Salis
CSChristoph Schwarzer
Christoph Schwarzer
MCMichelle Couzens
Michelle Couzens
SFSerguei Fetissov
Serguei Fetissov
SFSabine Furtinger
Sabine Furtinger
HHHerbert Herzog
Herbert Herzog
Neuropeptide Y is implicated in energy homeostasis, and contributes to obesity when hypothalamic levels remain chronically elevated. To investigate the specific role of hypothalamic Y2 receptors in this process, we used a conditional Y2 knockout model, using the Cre-lox system and adenoviral delivery of Cre-recombinase. Hypothalamus-specific Y2-deleted mice showed a significant decrease in body weight and a significant increase in food intake that was associated with increased mRNA levels for the orexigenic NPY and AgRP, as well as the anorexic proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) in the arcuate nucleus. These hypothalamic changes persisted until at least 34 days after Y2 deletion, yet the effect on body weight and food intake subsided within this time. Plasma concentrations of pancreatic polypeptide and corticosterone were 3- to 5-fold increased in hypothalamus-specific Y2 knockout mice. Germ-line Y2 receptor knockout also produced a significant increase in plasma levels of pancreatic polypeptide. However, these mice differed from conditional knockout mice in that they showed a sustained reduction in body weight and adiposity associated with increased NPY and AgRP but decreased POMC and CART mRNA levels in the arcuate nucleus. The transience of the observed effects on food intake and body weight in the hypothalamus-specific Y2 knockout mice, and the difference of this model from germ-line Y2 knockout mice, underline the importance of conditional models of gene deletion, because developmental, secondary, or extrahypothalamic mechanisms may mask such effects in germ-line knockouts.

19 January 2015 in Nature
Verified
Journal Article
Open access
PDF file
MGMasoud Ghamari-Langroudi
Masoud Ghamari-Langroudi
GDGregory J. Digby
Gregory J. Digby
JSJulien Sebag
Julien Sebag
GMGlenn L. Millhauser
Glenn L. Millhauser
RPRafael Palomino
Rafael Palomino
RCRoger D. Cone
Roger D. Cone
α-MSH and AgRP, two hypothalamus-derived peptides with opposing actions on the melanocortin-4 receptor (MC4R), modulate neurons driving feeding behaviour; although previous downstream mechanisms of cellular modulation by these peptides have been determined, here α-MSH and AgRP are shown to regulate neural activity by coupling MC4R to Kir7.1 potassium channels and closing or opening them, respectively. Food intake and energy storage are reciprocally controlled through the opposing actions of the hypothalamic peptides α-melanocyte stimulating hormone (α-MSH) and Agouti-related protein (AgRP) on the melanocortin-4 receptor (MC4R) that modulates neurons which drive feeding behaviour. This study identifies a previously unknown mechanism through which α-MSH and AgRP regulate firing activity of neurons from the paraventricular nucleus (PVN) of the hypothalamus. α-MSH is shown to couple MCR4 to Kir7.1 potassium channels, causing closure of the latter and enhancing PVN neural firing. AgRP has the opposite effects, causing Kir7.1 channels to open and inhibit PVN neuron firing. These mechanisms, independent of those previously identified, may explain several unusual properties specific to melanocortin signalling control of energy homeostasis and updates our neuroanatomical model. The regulated release of anorexigenic α-melanocyte stimulating hormone (α-MSH) and orexigenic Agouti-related protein (AgRP) from discrete hypothalamic arcuate neurons onto common target sites in the central nervous system has a fundamental role in the regulation of energy homeostasis. Both peptides bind with high affinity to the melanocortin-4 receptor (MC4R); existing data show that α-MSH is an agonist that couples the receptor to the Gαs signalling pathway1, while AgRP binds competitively to block α-MSH binding2 and blocks the constitutive activity mediated by the ligand-mimetic amino-terminal domain of the receptor3. Here we show that, in mice, regulation of firing activity of neurons from the paraventricular nucleus of the hypothalamus (PVN) by α-MSH and AgRP can be mediated independently of Gαs signalling by ligand-induced coupling of MC4R to closure of inwardly rectifying potassium channel, Kir7.1. Furthermore, AgRP is a biased agonist that hyperpolarizes neurons by binding to MC4R and opening Kir7.1, independently of its inhibition of α-MSH binding. Consequently, Kir7.1 signalling appears to be central to melanocortin-mediated regulation of energy homeostasis within the PVN. Coupling of MC4R to Kir7.1 may explain unusual aspects of the control of energy homeostasis by melanocortin signalling, including the gene dosage effect of MC4R4 and the sustained effects of AgRP on food intake5.

1 December 2014 in Cell Metabolism
Verified
Journal Article
Closed access
BPBrandon L. Panaro
Brandon L. Panaro
ITIain R. Tough
Iain R. Tough
MEMaja S. Engelstoft
Maja S. Engelstoft
RMRobert T. Matthews
Robert T. Matthews
GDGregory J. Digby
Gregory J. Digby
RCRoger D. Cone
Roger D. Cone

1 January 2006 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
SBSusan Brain
Susan Brain
HCHelen Cox
Helen Cox